These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 6336211)

  • 1. Clinical aspects of serotonin therapy of autoimmune disturbances.
    Abramchik GV; Leonovich AL; Ulashchik VS; Starostenko LI; Tanina RM
    Hum Physiol; 1984; 10(2):105-9. PubMed ID: 6336211
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical aspects of the therapy of autoimmune disorders using serotonin].
    Abramchik GV; Leonovich AL; Ulashchik VS; Starostenko LI; Tanina RM
    Fiziol Cheloveka; 1984; 10(2):255-9. PubMed ID: 6532837
    [No Abstract]   [Full Text] [Related]  

  • 3. [Thymectomy in disseminated sclerosis].
    Veĭn AM; Khomak VIa; Belokrinitskiĭ DV; Shkrob OS; Golubkov VA
    Sov Med; 1981; (12):42-5. PubMed ID: 6977873
    [No Abstract]   [Full Text] [Related]  

  • 4. [Will there soon be a sub-type specific treatment? New approaches to multiple sclerosis therapy].
    MMW Fortschr Med; 2008 Apr; 150(15):17. PubMed ID: 18510111
    [No Abstract]   [Full Text] [Related]  

  • 5. Multiple sclerosis is an inflammatory T-cell-mediated autoimmune disease.
    Weiner HL
    Arch Neurol; 2004 Oct; 61(10):1613-5. PubMed ID: 15477521
    [No Abstract]   [Full Text] [Related]  

  • 6. Potassium channels, memory T cells, and multiple sclerosis.
    Beeton C; Chandy KG
    Neuroscientist; 2005 Dec; 11(6):550-62. PubMed ID: 16282596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BAFF-targeting therapy, a promising strategy for treating autoimmune diseases.
    Sun J; Lin Z; Feng J; Li Y; Shen B
    Eur J Pharmacol; 2008 Nov; 597(1-3):1-5. PubMed ID: 18793632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aspects of cellular immunity in autoimmune thrombocytopenic purpura.
    Kaufman S; Peller S; Sigler E
    Isr J Med Sci; 1983 Mar; 19(3):271-3. PubMed ID: 6602117
    [No Abstract]   [Full Text] [Related]  

  • 9. Autoimmune diseases. The B cell slayer.
    Matthews R
    Science; 2007 Nov; 318(5854):1232-3. PubMed ID: 18033858
    [No Abstract]   [Full Text] [Related]  

  • 10. Bedside to bench: betting on B cells in multiple sclerosis.
    Link H
    Nat Med; 2008 Jun; 14(6):615-6. PubMed ID: 18535578
    [No Abstract]   [Full Text] [Related]  

  • 11. Copolymer 1 from the laboratory to FDA.
    Teitelbaum D; Sela M; Arnon R
    Isr J Med Sci; 1997 Apr; 33(4):280-4. PubMed ID: 9347880
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinico-immunologic parallels in evaluating the treatment of multiple sclerosis].
    Chernigovskaia NV; Ogurtsov RP; Matveeva TS; Popov VG; Puzyreva VP
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1990; 90(2):24-8. PubMed ID: 2160163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. B cell signalling as therapeutic target.
    Carter RH
    Ann Rheum Dis; 2004 Nov; 63 Suppl 2(Suppl 2):ii65-ii66. PubMed ID: 15479875
    [No Abstract]   [Full Text] [Related]  

  • 14. Epstein-Barr virus in the development of multiple sclerosis.
    Ascherio A
    Expert Rev Neurother; 2008 Mar; 8(3):331-3. PubMed ID: 18345964
    [No Abstract]   [Full Text] [Related]  

  • 15. Soluble CTLA-4 in autoimmune thyroid diseases: relationship with clinical status and possible role in the immune response dysregulation.
    Saverino D; Brizzolara R; Simone R; Chiappori A; Milintenda-Floriani F; Pesce G; Bagnasco M
    Clin Immunol; 2007 May; 123(2):190-8. PubMed ID: 17321799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinico-immunologic correlations in disseminated sclerosis].
    Zavalishin IA; Khondkarian OA; Nevskaia OM; Pivovarova AI
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1984; 84(2):164-7. PubMed ID: 6608842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunoregulation of autoimmunity by natural killer T cells.
    Linsen L; Somers V; Stinissen P
    Hum Immunol; 2005 Dec; 66(12):1193-202. PubMed ID: 16690406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparative analysis of the use of levamisole and pyrogenal in the treatment of multiple sclerosis].
    Mukhtarova AA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1985; 85(3):366-7. PubMed ID: 3873154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Defective production of anti-inflammatory cytokine, TGF-beta by T cell lines of patients with active multiple sclerosis.
    Mokhtarian F; Shi Y; Shirazian D; Morgante L; Miller A; Grob D
    J Immunol; 1994 Jun; 152(12):6003-10. PubMed ID: 8207225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Technology evaluation: abatacept, Bristol-Myers Squibb.
    Dumont FJ
    Curr Opin Mol Ther; 2004 Jun; 6(3):318-30. PubMed ID: 15264435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.